Type 1 diabetes runs in our family. Because of that, our pediatrician asked to do blood tests with our son to check if Type 1 is beginning. She also said that if it shows up, there’ s a medicine that ...

The market for generic GLP-1 weight loss drugs in Canada is set to open up, and Hims & Hers is ready to jump in.  | Novo ...

The participants in the trial – similar to two-thirds of breast cancer patients overall - had tumors that use the hormones ...

Inhaled insulin is effective for controlling blood sugar levels in children with diabetes, providing them with a ...

Despite the federal government’s recent implementation of zero import duty on pharmaceuticals and active pharmaceutical ...

While real-time data on how Indians are responding to these drugs is still emerging, experts say that sustained weight loss ...

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

In this 2025 public health alignment update, GlucoTru Pro emphasizes the growing consumer awareness of natural metabolic ...

Danish drugmaker Novo Nordisk is betting on its insulin leadership in India to dominate the country's $25-billion anti-obesity drug market with the imminent launch of its weight-loss therapy, a ...

For those living with diabetes, MannKind offers a very different alternative to the current methods of insulin delivery.

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.

CeQur announced today that it reached the milestone of 10 million mealtime insulin injections replaced with its Simplicity insulin patch.